This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Myeloid Cells
Organizer(s): Tiffany Horng, Gregory M. Barton and Ajay Chawla
Date: February 24 - 28, 2019
Location: Eldorado Hotel & Spa, Santa Fe, NM, USA
Sponsored by Bayer AG, Boehringer Ingelheim Pharmaceuticals, Inc., Compass Therapeutics and Genentech, Inc.

This activity is also supported by an educational grant from Celgene Corporation
Summary of Meeting:
Myeloid cells regulate tissue homeostasis, immunity, and inflammation, whereas their dysregulation contributes to cancer, metabolic, inflammatory diseases, and degenerative diseases. This Keystone Meeting will cover areas of long-standing interest as well as topical areas in the field of myeloid cell biology, including ontogeny and tissue specification, myeloid cell activation, immunometabolism, immunity and infection, mucosal immunity, and cancer immunology. Multiple myeloid cell populations will be discussed, including tissue resident macrophages, monocytes, dendritic cells, and neutrophils. The meeting will highlight the diverse approaches being used to study myeloid cell biology, including genomic analyses, single cell profiling, imaging, and metabolic profiling. Both basic and translational aspects of myeloid cell research will be covered. The goals of the meeting are to share recent advances in this rapidly evolving field, stimulate interactions between interdisciplinary groups of scientists, and define future areas of investigation in myeloid cell research.
Scholarship Deadline: October 24 2018
Discounted Abstract Deadline: October 24 2018
Abstract Deadline: November 28 2018
Discounted Registration Deadline: January 9 2019
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Bayer AGBoehringer Ingelheim Pharmaceuticals, Inc.Celgene CorporationCompass TherapeuticsGenentech, Inc.
We gratefully acknowledge additional support for this conference from:
Infinity Pharmaceuticals, Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1 R13 AI140577-01
Funding for this conference was made possible (in part) by 1 R13 AI140577-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found